Protective mechanisms of IVIG
- 31 December 2007
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 19 (6) , 646-651
- https://doi.org/10.1016/j.coi.2007.09.004
Abstract
No abstract availableThis publication has 55 references indexed in Scilit:
- Pharmacokinetic/Pharmacodynamic Modeling of IVIG Effects in a Murine Model of Immune ThrombocytopeniaJournal of Pharmaceutical Sciences, 2007
- Antibody-enhanced cross-presentation of self antigen breaks T cell toleranceJournal of Clinical Investigation, 2007
- Siglecs and their roles in the immune systemNature Reviews Immunology, 2007
- Plasmacytoid dendritic cell–specific receptor ILT7–FcεRIγ inhibits Toll-like receptor–induced interferon productionThe Journal of Experimental Medicine, 2006
- Intravenous Immunoglobulin for Autoimmune Thrombocytopenic PurpuraHuman Immunology, 2005
- Identification of FcαRI as an Inhibitory Receptor that Controls InflammationDual Role of FcRγ ITAMImmunity, 2005
- Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular ToxicityJournal of Biological Chemistry, 2002
- Treatment of Refractory Immune Thrombocytopenic Purpura with an Anti-Fcγ-Receptor AntibodyNew England Journal of Medicine, 1986
- Transient Reversal of Thrombocytopenia in Idiopathic Thrombocytopenic Purpura by High-Dose Intravenous Gamma GlobulinNew England Journal of Medicine, 1982
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOODThe Lancet, 1981